Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision

Webinar Oncology & Hematology
Date: 2025
Time: N/A
Location: Online
Watch on demand
Summary
In today's patient-centric landscape, precision-driven omnichannel strategies are essential to engage HCPs at the right time, within the critical treatment decision window to improve patient outcomes. This webinar will provide actionable insights into how real-world data-driven engagement can reach HCPs in as little as 24 hours before a treatment decision is made. 
Key Learning Objectives:
  • Gain insight into how a multi-modal approach to data enables precise targeting of HCPs. - Explore the shift in physician engagement and how a digital first approach cuts through the noise in clinical education.
  • Gain insight into how real-world data informed omni-channel strategies enable physicians to be engaged in as little as 24 hours before a treatment decision has been made.
  • Perspectives: Hear from pharma leaders about the current challenges in reaching and engaging relevant physicians to ensure commercial launch success.
Speakers:
Gosia Leitch
VP of Engagement Solutions

Leading our Engagement Solutions, Gosia designs and delivers data-driven HCP engagement strategies that help pharma partners unlock the full potential of diagnostically driven therapies and accelerate biomarker and treatment adoption. 

Since joining Diaceutics in 2024, Gosia has been pivotal in scaling Engagement Solutions, sharpening our commercial proposition and driving deeper utilisation of genomics and oncology diagnostics across global pharma accounts. 

With 20+ years in diagnostics and pharma, including senior roles at Veracyte, Abbott and Bayer, Gosia brings expertise in commercial strategy, brand management and HCP education. She holds an MBA from the University of Iowa and executive education in Corporate Strategy from Columbia Business School.  

 

Connect
Scott Phillips
Vice President of Real World Data
As Vice President of Real World Data, Scott leads the incubation and development of Diaceutics' Real World Data business unit, driving channel partnerships, new product offerings, and the integration of advanced data and AI capabilities into our platform. A HealthTech executive specialising in real-world data, AI strategy, and commercial growth, he brings deep expertise in scaling complex data products from inception to market leadership. His career has been shaped by senior roles at Komodo Health and COTA Healthcare, alongside strategic consulting at L.E.K. Consulting. An MBA graduate of Harvard Business School, his leadership accelerates commercial growth and strengthens our real-world evidence offering for pharma.  Connect
Sopheara Peoples
Senior Director, Head of OncologyDigital, Data and TechnologyUS Pharma, GSK
Sopheara Peoples is a strategic digital and technology leader specializing in enterprise data, AI, and machine learning. At GSK, Sopheara leverages real-world evidence (RWE) and advanced analytics to drive business transformation and decision-making. With deep expertise in Generative AI, predictive modelling, and business intelligence, she leads cross-functional teams to implement scalable data solutions.  Connect
Gunjan Aggarwal
Executive Director - Insights &Decision Science, Novartis
Gunjan Aggarwal is a healthcare data strategist with extensive experience in digital transformation, analytics, and precision medicine. As Executive Director at Novartis, she leads initiatives that enhance data-driven marketing and patient-centric solutions. Passionate about reimagining healthcare, Gunjan applies AI and emerging technologies to drive operational efficiency and innovation.  Connect

Watch on demand

HCP Engagement & Activation Data & AI Oncology & Hematology Launch Post-launch
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.